Don't kid yourself by cutting down on cigarettes

According to new research smokers who believe they are reducing their risk for heart disease by cutting back on cigarettes, are kidding themselves.

The research apparently shows that the difference between a non-smoker and one who smokes one to four cigarettes a day is negligible and both will end up in an early grave.

Researcher Dr. Kjell Bjartveit believes smokers who are led to believe cutting down will be of benefit are being offered false expectations and the only safe way out is to quit smoking entirely.

A study by Norwegian scientists looked at 51,000 men and women aged between 20 and 34, who were grouped into non-smokers, moderate smokers, and reducers -- those who cut their intake of more than 15 cigarettes a day in half as the study progressed.

The participants were assessed for cardiovascular risk factors at the start of the study, and then monitored for an average period of more than 20 years.

The researchers found that smokers who cut their daily nicotine intake in half still had the same chance of premature death.

The death rate of the men who cut back and the heavy smokers were comparable but the women who cut back had a higher death rate then the heavy smokers.

Critics say such studies can be misleading as smokers also tend to lead generally unhealthy lives, have poor diets and do little exercise.

The study is published in the journal Tobacco Control.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Titrzepatide reduces risk of death or worsening heart failure for patients with obesity-related heart failure